These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17162660)

  • 21. Role of macrophages in restricting herpes simplex virus type 1 growth after ocular infection.
    Cheng H; Tumpey TM; Staats HF; van Rooijen N; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1402-9. PubMed ID: 10798656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of cytokine mRNAs in murine herpes simplex virus type 1 retinitis.
    Saitoh-Ishibashi K; Ishibashi K; Azumi A; Negi A
    Jpn J Ophthalmol; 2003; 47(2):166-72. PubMed ID: 12738550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA microarray analysis of the uninoculated eye following anterior chamber inoculation of HSV-1.
    Zheng M; Qian H; Joshi RM; Nechtman J; Atherton SS
    Ocul Immunol Inflamm; 2003 Sep; 11(3):187-95. PubMed ID: 14566645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of antisense oligonucleotides targeting tumor necrosis factor-alpha on experimental herpetic-induced chorioretinitis of mouse eye.
    Mei H; Xing Y; Yang J; Wang A; Xu Y; Heiligenhaus A
    Pathobiology; 2009; 76(1):45-50. PubMed ID: 19188750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
    Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
    Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Delayed spread and reduction in virus titer after anterior chamber inoculation of a recombinant of HSV-1 expressing IL-16.
    Archin NM; van den Boom L; Perelygina L; Hilliard JM; Atherton SS
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3066-76. PubMed ID: 12824253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of IFN-gamma and tumor necrosis factor-alpha in herpes simplex virus type 1 infection.
    Minami M; Kita M; Yan XQ; Yamamoto T; Iida T; Sekikawa K; Iwakura Y; Imanishi J
    J Interferon Cytokine Res; 2002 Jun; 22(6):671-6. PubMed ID: 12162877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of herpes simplex hepatitis in macrophage-depleted mice: possible involvement of tumor necrosis factor-alpha and inducible nitric oxide synthase in massive apoptosis.
    Irie H; Shiga J
    Anat Sci Int; 2005 Dec; 80(4):199-211. PubMed ID: 16333916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1.
    Rossol-Voth R; Rossol S; Schütt KH; Corridori S; de Cian W; Falke D
    J Gen Virol; 1991 Jan; 72 ( Pt 1)():143-7. PubMed ID: 1703559
    [TBL] [Abstract][Full Text] [Related]  

  • 30.
    Brun P; Qesari M; Marconi PC; Kotsafti A; Porzionato A; Macchi V; Schwendener RA; Scarpa M; Giron MC; Palù G; Calistri A; Castagliuolo I
    Front Cell Infect Microbiol; 2018; 8():74. PubMed ID: 29600197
    [No Abstract]   [Full Text] [Related]  

  • 31. Spread and replication of and immune response to gamma134.5-negative herpes simplex virus type 1 vectors in BALB/c mice.
    Broberg EK; Peltoniemi J; Nygårdas M; Vahlberg T; Röyttä M; Hukkanen V
    J Virol; 2004 Dec; 78(23):13139-52. PubMed ID: 15542666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of NO production in macrophages by IL-13 is counteracted by Herpes simplex virus infection through tumor necrosis factor-alpha-induced activation of NK-kappa B.
    Paludan SR; Ellermann-Eriksen S; Malmgaard L; Mogensen SC
    Eur Cytokine Netw; 2000 Jun; 11(2):275-82. PubMed ID: 10903807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of valacyclovir with an anti-TNF alpha antibody increases survival rate compared to antiviral therapy alone in a murine model of herpes simplex virus encephalitis.
    Boivin N; Menasria R; Piret J; Rivest S; Boivin G
    Antiviral Res; 2013 Dec; 100(3):649-53. PubMed ID: 24416771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumoricidal activity of high-dose tumor necrosis factor-alpha is mediated by macrophage-derived nitric oxide burst and permanent blood flow shutdown.
    Menon C; Bauer TW; Kelley ST; Raz DJ; Bleier JI; Patel K; Steele K; Prabakaran I; Shifrin A; Buerk DG; Sehgal CM; Fraker DL
    Int J Cancer; 2008 Jul; 123(2):464-475. PubMed ID: 18449880
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virus-cell interactions regulating induction of tumor necrosis factor alpha production in macrophages infected with herpes simplex virus.
    Paludan SR; Mogensen SC
    J Virol; 2001 Nov; 75(21):10170-8. PubMed ID: 11581385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of B lymphocytes in experimental herpes simplex viral retinitis.
    Arrunategui-Correa V; Dutt J; Foster CS
    Scand J Immunol; 1994 Sep; 40(3):299-307. PubMed ID: 8091129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-depletion influences the course of murine HSV-1 keratitis.
    Bauer D; Mrzyk S; van Rooijen N; Steuhl KP; Heiligenhaus A
    Curr Eye Res; 2000 Jan; 20(1):45-53. PubMed ID: 10611714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections.
    Heise MT; Virgin HW
    J Virol; 1995 Feb; 69(2):904-9. PubMed ID: 7815559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HSV-1 retinitis and delayed hypersensitivity in DBA/2 and C57BL/6 mice.
    Kielty D; Cousins SW; Atherton SS
    Invest Ophthalmol Vis Sci; 1987 Dec; 28(12):1994-9. PubMed ID: 2824401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of herpes simplex virus infection in the pathogenesis of facial paralysis in mice.
    Murakami S; Hato N; Mizobuchi M; Doi T; Yanagihara N
    Ann Otol Rhinol Laryngol; 1996 Jan; 105(1):49-53. PubMed ID: 8546424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.